Skip to main content
. 2020 Sep 11;70(3):635–643. doi: 10.1007/s12020-020-02481-4

Table 1.

Hormonal and metabolic parameters of subjects with FHA under study

LH mIU/mL FSH mIU/mL E2 pg/mL T ng/mL PRL ng/mL TSH µIU/mL fT4 ng/dL Cortisol nmol/L DHEAS µmol/L Insulin µU/mL Glucose mg/dL Total Cholest mg/dL LDL mg/dL HDL mg/dL Triglic mg/dL CRP mg/L BMI (kg/m²)
All patients (n = 71) 1.7 ± 0.1 4.3 ± 0.2 16.4 ± 1.5 0.2 ± 0.01 8.4 ± 0.5 1.7 ± 0.08 1.2 ± 0.05 458.6 ± 16.6 7.2 ± 0.2 5.9 ± 0.3 84.6 ± 1.0 191.7 ± 4.1 100.8 ± 4.3 79.7 ± 2.6 73.5 ± 3.3 1.1 ± 0.4 19.8 ± 0.2
Hypo-LH (n = 58) 1.2 ± 0.1 4.0 ± 0.2 16.8 ± 1.7 0.2 ± 0.01 8.0 ± 0.6 1.6 ± 0.09 1.2 ± 0.07 466.6 ± 18.7 7.1 ± 0.2 6.1 ± 0.3 84.6 ± 1.2 191.3 ± 4.4 103.6 ± 4.8 76.4 ± 2.5 73.2 ± 3.6 1.2 ± 0.5 19.7 ± 0.2
**** *** * **
Normo-LH (n = 13) 4.1 ± 0.1 5.6 ± 0.5 15.0 ± 3.7 0.3 ± 0.04 10.0 ± 1.2 1.9 ± 0.2 1.2 ± 0.05 402.5 ± 33.4 7.5 ± 0.6 5.0 ± 0.5 83.7 ± 0.2 197 ± 11.1 89.0 ± 8.4 97.2 ± 7.8 75.0 ± 8.3 0.4 ± 0.1 19.8 ± 0.2

****p < 0.000001; ***p < 0.001; **p < 0.005; *p < 0.01 vs normo-LH patients